49.16 USD
↘ 0.00 (0.01%)PRE MARKET (AS OF 07:31 PM EDT)
ALKS is currently priced at $49.16. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a weak Piotroski F-Score of 2/9 and a bullish Golden Cross on the moving averages. On the valuation front, ALKS trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Aug 26, 2026.
Open?$49.23
High?$50.00
Low?$47.31
Prev. Close?$49.16
Volume?488.9K
Avg. Volume?1.5M
VWAP?$49.09
Rel. Volume?0.32x
Bid / Ask
Bid?$42.08 × 100
Ask?$56.01 × 100
Spread?$13.93
Midpoint?$49.05
Valuation & Ratios
Market Cap?8.2B
Shares Out?167.8M
Float?164.0M
Float %?98.4%
P/E Ratio?124.73
P/B Ratio?4.56
EPS?$0.39
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Employees
2.0K
Market Cap
8.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1991-07-16
Address
CONNAUGHT HOUSE
DUBLIN 4, L2 00000
Phone: 00-353-1-772-8000
DUBLIN 4, L2 00000
Phone: 00-353-1-772-8000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?49
Momentum?8
Short Sent.?48
Piotroski F-Score?2/9Weak
Altman Z-Score?2.36Grey
Confidence?70%Moderate
Short InterestVery High
Short % of Float?9.00%Elevated
Short Interest?14.8M
Days to Cover?10.2
Free Float164.0M
Avg Daily Volume1.4M
Settlement Date2026-08-14
Financial Health
Current Ratio?2.30Strong
Quick Ratio?1.85Adequate
Cash Ratio?0.77Adequate
Debt/Equity?0.83Moderate
ValuationRICHLY VALUEDvs 4 peers + S&P 500
Score50/100
P/E?124.7PRICEY▾
Peers25
S&P3
P/B?4.56FAIR▾
Peers40
S&P40
P/S?4.95FAIR▾
Peers60
S&P29
P/FCF?37.2PRICEY▾
Peers25
S&P19
EV/EBITDA?45.0HIGH▾
Peers25
S&P3
EV/Sales?5.54FAIR▾
Peers60
S&P32
Returns & Efficiency
ROE?3.7%WEAK▾
Peers50
S&P18
ROA?1.5%WEAK▾
Peers25
S&P16
Cash Flow & Enterprise
FCF?$221.7M
Enterprise Value?$9.2B
Fundamentals ratios updated end of day